NORTHERN TRUST CORP - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 93 filers reported holding EIDOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$17,911,000
+155.7%
136,117
-1.8%
0.00%
+50.0%
Q3 2020$7,006,000
+8.1%
138,660
+1.9%
0.00%0.0%
Q2 2020$6,484,000
-5.9%
136,020
-3.3%
0.00%0.0%
Q1 2020$6,892,000
-14.2%
140,685
+0.5%
0.00%0.0%
Q4 2019$8,031,000
+55.5%
139,935
-2.5%
0.00%
+100.0%
Q3 2019$5,163,000
-9.8%
143,553
-22.0%
0.00%0.0%
Q2 2019$5,723,000
+34.5%
184,115
+1.5%
0.00%0.0%
Q1 2019$4,255,000
+227.1%
181,468
+91.8%
0.00%
Q4 2018$1,301,000
+44.9%
94,601
+5.1%
0.00%
Q3 2018$898,000
+219.6%
90,007
+551.0%
0.00%
Q2 2018$281,00013,8250.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders